Loading
Privia Health Group, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 13 Jun 2024.
Privia Health Group, Inc.: what insiders have been doing
Privia Health Group, Inc. belongs to the Healthcare & Pharma sector. Filings by its managers are published through SEC (Form 4). From 18 October 2025 to 18 October 2026, the disclosure feed for Privia Health Group, Inc. logged 31 filings by 8 insiders.
Only sales appear on the open market, 16 sales in all totalling €8.3M, filed by 4 insiders. Mehrotra Parth filed the largest sale, €2.0M, on 13 May 2026, which represents 0.070% of the company's market value.
Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
With 31 filings in twelve months, the company is more active than the median of 19 filings across the 5,811 companies we follow on the same exchange. Since 2021, the database holds 5 purchases and 96 sales by insiders of the company. The 10-K for the year ended 31 December 2025 shows 2.12 bn USD of revenue and 22.9 m USD of net income.
For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Anixa Biosciences Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
269
Thresholds
n/a
Buy Volume
€4M
5 ops. · all time
Sell Volume
€1B
96 ops. · all time
Who traded when
BuySaleDavid Mountcastle13 sales
Parth Mehrotra9 sales
Matthew Shawn Morris3 sales
Edward C. Fargis2 sales
Since the insiders bought
- +31.0%Entry US$17.47 · Close at T+365 US$22.89
- -33.4%Entry US$32.81 · Close at T+365 US$21.84
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Privia Health Group, Inc. Strong Buy (bullish), based on 17 analysts. Average price target: US$31.47.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 14,008 of 24,148 companies
46.9
score / 100
Value52
Quality42
FCF yld5.7%
Earn yld0.8%
EV/EBITDA·
ROE4.3%
Gross mgn9.9%
Net mgn1.1%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$22.62
Analyst consensus
17 analystsStrong buy
US$24.00Target US$31.47(+39%)US$40.00
Income statement
RevenueUS$2.1B
Gross profitUS$209.4M10% margin
EBITDAUS$44.1M2% margin
Net incomeUS$22.9M1.2% margin
Valuation
PER (trailing)107.7x
PER (forward)21.3x
P/Book3.7x
Beta0.80
Balance sheet & cash
Market capUS$2.9B
Total debtUS$9.5M
Free Cash FlowUS$163.4M
Debt / Equity1%
Profitability & ownership
ROE4.3%
ROA2.0%
% insiders6.2%
% institutions99.1%
Last declaration on 3 September 2026
Declarations269 total
6,350 shares0Common Stock, $0.01 par value per shareSEC:0001759655-26-000076:0
21,275 shares@ US$27.670.023% mcap6.6% of flowCommon Stock, par value $0.01 per shareSEC:0001759655-26-000057:0
21,275 shares@ US$27.66640.023% mcap6.6% of flowCommonSEC144:0001959173-26-005184
600 shares@ US$27.570.0007% mcap0.2% of flowCommon Stock, par value $0.01 per shareSEC:0001858396-26-000016:0
600 shares@ US$27.5650.0007% mcap0.2% of flowCommonSEC144:0001959173-26-005147
59,037 shares@ US$2.000.0047% mcap1.9% of flowCommon Stock, par value $0.01 per shareSEC:0001401958-26-000010:0
59,037 shares@ US$27.330.064% mcap25.8% of flowCommon Stock, par value $0.01 per shareSEC:0001401958-26-000010:1
53,722 shares@ US$2.000.0042% mcap1.7% of flowCommon Stock, par value $0.01 per shareSEC:0001401958-26-000010:2
53,722 shares@ US$27.240.058% mcap23.4% of flowCommon Stock, par value $0.01 per shareSEC:0001401958-26-000010:3
24,734 shares@ US$27.500.027% mcap7.6% of flowCommon Stock, par value $0.01 per shareSEC:0001858396-26-000014:0
24,734 shares@ US$27.50010.027% mcap7.6% of flowCommonSEC144:0001959173-26-005071
17,196 shares@ US$25.18240.012% mcap4.9% of flowCommonSEC144:0001959173-26-004929
8,463 shares0Common Stock, $0.01 par value per shareSEC:0001759655-26-000043:0
8,463 shares0Common Stock, $0.01 par value per shareSEC:0001759655-26-000042:0
105,439 shares@ US$22.550.070% mcap24.5% of flowCommon Stock, $0.01 par value per shareSEC:0001759655-26-000030:0
3,385 shares@ US$22.600.0022% mcap0.8% of flowCommon Stock, par value $0.01 per shareSEC:0001858396-26-000011:0
5,566 shares@ US$20.850.0035% mcap1.3% of flowCommon Stock, par value $0.01 per shareSEC:0001858396-26-000006:0
6,391 shares@ US$22.111.6% of flowCommon Stock, par value $0.01 per shareSEC:0001759655-26-000019:0
26,509 shares@ US$22.116.2% of flowCommon Stock, $0.01 par value per shareSEC:0001858398-26-000006:0
6,453 shares@ US$21.901.6% of flowCommon Stock, par value $0.01 per shareSEC:0001858396-26-000003:0
26,763 shares@ US$21.906.2% of flowCommon Stock, $0.01 par value per shareSEC:0001858398-26-000004:0
21,097 shares@ US$22.715.0% of flowCommon Stock, $0.01 par value per shareSEC:0001858398-26-000002:0
28,268 shares0Common Stock, $0.01 par value per shareSEC:0002009323-26-000002:0
35,335 shares0Common Stock, par value $0.01 per shareSEC:0001858396-26-000001:0
4,394 shares@ US$23.1560.5% of flowCommon Stock, $0.01 par value per shareSEC:0001759655-26-000016:0
25 of 269 declarations
About Privia Health Group, Inc.
Privia Health Group, Inc. (ticker: PRVA) is a U.S.-listed healthcare company trading on the NASDAQ market in the United States. Privia is best understood as a physician-enablement platform rather than a traditional provider or insurer. Its model is built to help physicians, medical groups, health plans, and health systems deliver better coordinated care, improve patient outcomes, and lower total healthcare costs. The company combines regional medical groups, physician-led governance, management services organizations, and a cloud-based technology and analytics stack that supports population health, workflow efficiency, care-gap management, and value-based care execution.
Founded in 2007, Privia has grown from a regional physician platform into a national organization. Its headquarters are in Arlington, Virginia, which places the company close to major U.S. healthcare policy, payer, and provider networks. Over time, Privia expanded beyond its Mid-Atlantic roots into multiple U.S. markets, including Virginia, Maryland, and Washington, D.C., as well as Georgia, Texas, Florida, Tennessee, California, Montana, Ohio, North Carolina, Connecticut, Washington state, South Carolina, and Indiana. That geographic expansion reflects a deliberate market-by-market rollout strategy, with local operating structures adapted to each state’s regulatory and payer environment.
Read moreShow less
The company’s core business lines center on organizing primary-care and multi-specialty physician practices, providing practice management support, and enabling participation in value-based care arrangements. Through local MSOs and associated medical groups, Privia supports provider contracting, reimbursement negotiations, patient records management, and population-health programs. It also participates in accountable care organization structures, including Privia-owned ACOs, allowing the company to monetize performance-based reimbursement models and deepen its involvement in Medicare and commercial value-based care. In practical terms, Privia’s competitive advantage lies in offering physicians scale, operational infrastructure, and technology while preserving a high degree of clinical autonomy.
Competitively, Privia sits in an attractive but demanding segment of U.S. healthcare services. It competes for physician affiliation, payer relationships, and market share in value-based care, where execution quality and local physician trust matter as much as technology. Its platform approach differentiates it from pure administrative outsourcing models, while its physician-led structure helps support retention and practice engagement.
Recent developments have reinforced the investment case. In 2025, Privia reported strong financial and operating momentum, including revenue growth, improved operating profit, and continued additions of implemented providers and attributed lives. The company also announced an agreement in September 2025 to acquire an ACO business from Evolent Health, expanding its value-based care footprint and adding attributed lives across commercial, Medicare, Medicare Advantage, and Medicaid arrangements. For investors, PRVA is a healthcare technology-and-services compounder listed on NASDAQ in the United States, with exposure to the secular shift toward coordinated care, risk-bearing provider models, and physician-led network consolidation.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
